arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2406.13162cs.LGcs.AIq-bio.QM
收藏

AntibodyFlow:用于设计抗体互补决定区的归一化流模型

AntibodyFlow: Normalizing Flow Model for Designing Antibody Complementarity-Determining Regions

School of Electrical Engineering and Computer Science, Nanjing University of Aeronautics and Astronautics(南京航空航天大学电子工程与计算机科学学院);School of Computer Science and Technology, North University of China(中北大学计算机科学与技术学院);School of Semiconductor and Physics, North University of China(中北大学半导体与物理学院)

Bohao Xu, Yanbo Wang, Wenyu Chen, Shimin Shan

AI总结:

针对抗体CDR环3D几何结构学习难题,提出3D流模型AntibodyFlow,通过构建距离矩阵预测氨基酸并结合约束学习生成有效结构,在有效率和RMSD上均优于现有基线。

摘要:

过去几十年中,治疗性抗体在药物发现与开发领域得到了广泛研究。抗体是一类特异性保护蛋白,以“锁钥”方式与抗原结合。抗体与特定抗原之间的结合强度/亲和力很大程度上由抗体上的互补决定区(CDRs)决定。现有机器学习方法将计算机辅助CDR开发建模为序列或(单链)3D图生成任务,并已取得初步成功。然而,由于CDR环具有特定的几何形状,学习CDR的3D几何结构仍然是一项挑战。为解决这一问题,我们提出AntibodyFlow——一种用于设计抗体CDR环的3D流模型。具体而言,AntibodyFlow首先构建距离矩阵,然后基于该距离矩阵预测氨基酸。此外,AntibodyFlow还进行约束学习和约束生成,以确保3D结构的有效性。实验结果表明,AntibodyFlow始终优于最优基线模型,在有效率上相对提升最高达16.0%,在几何图级误差(均方根偏差,RMSD)上相对降低最高达24.3%。

英文摘要:

Therapeutic antibodies have been extensively studied in drug discovery and development in the past decades. Antibodies are specialized protective proteins that bind to antigens in a lock-to-key manner. The binding strength/affinity between an antibody and a specific antigen is heavily determined by the complementarity-determining regions (CDRs) on the antibodies. Existing machine learning methods cast in silico development of CDRs as either sequence or 3D graph (with a single chain) generation tasks and have achieved initial success. However, with CDR loops having specific geometry shapes, learning the 3D geometric structures of CDRs remains a challenge. To address this issue, we propose AntibodyFlow, a 3D flow model to design antibody CDR loops. Specifically, AntibodyFlow first constructs the distance matrix, then predicts amino acids conditioned on the distance matrix. Also, AntibodyFlow conducts constraint learning and constrained generation to ensure valid 3D structures. Experimental results indicate that AntibodyFlow outperforms the best baseline consistently with up to 16.0% relative improvement in validity rate and 24.3% relative reduction in geometric graph level error (root mean square deviation, RMSD).

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑